Osteoarthritis is a disease of the joints. His risk factors? Aging, sports or professional joint trauma, obesity or even heredity. Ten million French people are affected by osteoarthritis, including 65% of those over 65, and up to 80% of those over 80. Osteoarthritis has been responsible for 5 million work stoppages over the past 10 years. It is the first cause of invalidity for people over 40, the second cause of consultation with the general practitioner. This is to say if osteoarthritis is a serious disease.
Arthelio®the 1st Postbiotic to provide lasting relief for patients suffering from osteoarthritis
The intestinal microbiota is a new target for treating osteoarthritis. We know that there is a link between intestinal dysbiosis (an imbalance of the intestinal flora) and the progression of osteoarthritis. A gut microbiota imbalance or dysbiosis increases the permeability of the intestinal mucosa allowing the passage of bacterial endotoxins in the blood and causing micro-inflammations, especially in the joints. Arthelio®, first postbiotic innovation in joint discomfort, is the unique combination of vitamin C, which contributes to the normal formation of collagen to ensure the normal function of the cartilage and a total culture of Bifidobacterium longum CBi0703® from the intestinal microbiota. This dietary supplement acts by inhibiting the passage of endotoxins, which cause joint micro-inflammation, through the intestinal mucosa.
Namely: Arthelio® targets all the cartilages of your joints, whatever your age or their degree of degradation.
Arthelio® decreases the intensity, duration and frequency of osteoarthritic pain attacks.
This combination of ingredients, unique in the world, allows arthelio®:
- reduce the intensity of joint discomfort regardless of the joint concerned
- reduce the number of peaks of discomfort
A usage survey conducted on a panel of 335 consumers representative of the French osteoarthritis population showed a 30% drop in the number of osteoarthritis patients suffering on a daily basis, shorter, less frequent and less painful osteoarthritis attacks, an increase 54% of the number of patients no longer being hampered in their daily activities and a 72% drop in the consumption of analgesics and anti-inflammatories. (1)
His advantages ? One small capsule per day easy to swallow, without titanium dioxide and without bulking agent, no observed side effects or known drug interactions for benefits acquired in less than 3 months.
Usage tips:
1 capsule per day, in cure of 3 months, to renew according to the needs.
Availability: pharmacies, parapharmacies and on arthelio.fr
Average price noted: €35 for a 3-month treatment
Learn more about immubio products
On the occasion of the Top Health Awards, we invite you to vote for your Coup de Coeur product. Do you want to vote for Arthelio? It’s this way !
(1) After 3 months of treatment with Arthélio® (1 capsule/day) in 320 patients suffering from osteoarthritis. Henrotin Y. Rheumatos, October 2020 vol17;157 (2)
* A Postbiotic is a preparation of inactivated micro-organisms and their metabolites which confers an advantage for our organism.
On the occasion of the Top Health Awards, we award a Public Favorite Award. Do you want to vote for Arthélio? It’s this way !
